All enrolled patients who received at the very least one particular dose of zosuquidar or placebo during induction have been monitored to the occurrence of adverse events (439 people, 219 on zosuquidar and 210 on placebo). The most typical adverse functions were connected to the period of extended and major https://cdk8-in-181357.blazingblog.com/28122814/5-simple-techniques-for-gw7647